TMU Research Center of Cancer Translational Medicine

Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Whang-Peng, J.


Project: B - Project of TMUh - Other (Funded by TMU)


Whang-Peng, J.


Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: An observational, descriptive study

    Brauer, R., Wong, I. C. K., Man, K. K. C., Pratt, N. L., Park, R. W., Cho, S. Y., Li, Y. C., Iqbal, U., Nguyen, P. A. A. & Schuemie, M., Jan 13 2020, In : BMJ Open. 10, 1, p. e032426 032426.

    Research output: Contribution to journalArticle

    Open Access
  • AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis

    Chen, T. C., Chuang, J. Y., Ko, C. Y., Kao, T. J., Yang, P. Y., Yu, C. H., Liu, M. S., Hu, S. L., Tsai, Y. T., Chan, H., Chang, W. C. & Hsu, T. I., Feb 1 2020, In : Redox Biology. 30, p. 101413 101413.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)